BCC Research Reports on DNA Sequencing Market

August 15, 2008

Wellesley, MA – According to a new technical market research report from BCC Research titled “DNA Sequencing: Emerging technologies and Applications,” the global market for DNA sequencing technology was worth $794.0 million in 2007 and an estimated $862.5 million in 2008. This should increase to $1.7 billion by 2013, a compound annual growth rate (CAGR) of 14.7%.

The market is broken down into the segments of research/drug discovery and development, commercial applications and emerging applications.

Research/drug discovery and development has the largest share of the market, generating $600.4 million in 2007. This is expected to increase to $640.6 million in 2008 and over $1.0 billion in 2013, for a CAGR of 9.7%.

Commercial applications have the next largest share of the market, worth $193.6 million in 2007 and an estimated $218.8 million in 2008. This should increase at a CAGR of 14.3% to reach $426.1 million in 2013.

Emerging applications have the smallest but fastest growing share of the market. This sector is expected to generate $3.1 million by the end of 2008 and $272.5 million in 2013, for a CAGR of 144.8%.

 DNA sequencing allows us to catalogue the variations within the human genome sequence that make us phenotypically different, and that cause resistance and susceptibility to disease.

The rapidly evolving sequencing technologies provide unprecedented analytical tools that allow us to identify this sequence variation, in humans as well as in other species.

 Technology and market forces are working a fundamental shift in the DNA sequencing industry away from stagnant/declining growth towards high growth.

This growth inflection signals the arrival of DNA sequencing as a premier genetic analysis tool: useful for existing applications such as de novo whole genome sequencing and entirely new applications like epigenetic tag sequencing.¹

¹OBBeC.com

read more | digg story

Bookmark and Share

Advertisements

Global Market for DNA Sequencing Worth $1.7 Billion by 2013

August 11, 2008

Wellesley, Mass—According to a new technical market research report, DNA SEQUENCING: EMERGING TECHNOLOGIES AND APPLICATIONS (BIO045B) from BCC Research, the global market for DNA sequencing technology was worth $794.0 million in 2007 and an estimated $862.5 million in 2008. This should increase to $1.7 billion by 2013, a compound annual growth rate (CAGR) of 14.7%.

The market is broken down into the segments of research/drug discovery and development, commercial applications and emerging applications. Research/drug discovery and development has the largest share of the market, generating $600.4 million in 2007. This is expected to increase to $640.6 million in 2008 and over $1.0 billion in 2013, for a CAGR of 9.7%.

Commercial applications have the next largest share of the market, worth $193.6 million in 2007 and an estimated $218.8 million in 2008. This should increase at a CAGR of 14.3% to reach $426.1 million in 2013.

Emerging applications have the smallest but fastest growing share of the market. This sector is expected to generate $3.1 million by the end of 2008 and $272.5 million in 2013, for a CAGR of 144.8%.

DNA sequencing allows us to catalogue the variations within the human genome sequence that make us phenotypically different, and that cause resistance and susceptibility to disease. The rapidly evolving sequencing technologies provide unprecedented analytical tools that allow us to identify this sequence variation, in humans as well as in other species.

Technology and market forces are working a fundamental shift in the DNA sequencing industry away from stagnant/declining growth towards high growth. This growth inflection signals the arrival of DNA sequencing as a premier genetic analysis tool: useful for existing applications such as de novo whole genome sequencing and entirely new applications like epigenetic tag sequencing.

FIGURE
GLOBAL VALUE OF DNA SEQUENCING, BY END USE APPLICATION,
2006-2013
($ millions)

read more | digg story

Bookmark and Share


Stem Cell Development Continuing at a Blistering Speed

August 1, 2008

US MARKET FOR STEM CELL TECHNOLOGIES SLATED FOR HIGH GROWTH THROUGH 2012

Wellesley, Mass—According to a new technical market research report, STEM CELL TECHNOLOGY: CURRENT APPLICATIONS AND FUTURE DIRECTIONS (BIO035C) from BCC Research, the domestic market for stem cell technology is expected to increase from $112.0 million in 2007 to $423.1 million in 2012, a compound annual growth rate (CAGR) of 30.5%

The market is divided into cellular therapeutics and therapeutic banking categories. Stem cells in therapeutic banking have the larger share of the market, worth $65.9 million in 2007 and expected to increase to $155.7 million in 2012, for a CAGR of 18.8%.

Cellular therapeutics should be the faster growing segment. Cellular therapeutics generated $46.1 million in 2007 and is expected to generate $267.4 million in 2012, a CAGR of 42.1%.

The advent of stem cell technology has reignited the regenerative medicine market with hopes of powerful new therapeutics geared towards addressing unmet healthcare needs such as cardiovascular disease, neurological diseases, metabolic diseases, organ failure, a wide range of injuries, and even age related degeneration.

Although stem cell based therapeutics hold great promise, the delivery of actual readily available treatments is still projected to be at least five if not 10 or more years away. People looking to capitalize on the potential future therapeutic applications of stem cells have been preserving their stem cells, and stem cell banking has become a slow but growing market.

Stem cell research and development will continue to play a significant role in the present and future commercialization of stem cell based products and services and may develop into a substantial parallel market to stem cell based therapeutics as these tools mature, and potentially move into adjacent life science markets such as pharmaceutical testing and drug discovery.

Contact: Jason W. Prokowiew

Tel: 978-870-3345

Email: jason.prokowiew@bccresearch.com

read more | digg story

Bookmark and Share


DNA Vaccine Development Making Strides

July 9, 2008

While traditional antigen-based products will continue to dominate the sector, the benefits offered by DNA vaccines in terms of minimized side effect profile make any successful technology an attractive proposition.¹

¹Gareth Macdonald; In-pharmatechnologist.com

read more | digg story

Bookmark and Share


Global Market for DNA Diagnostics Technologies

July 8, 2008

According to a new technical market research report, DNA DIAGNOSTICS: TECHNOLOGIES AND GLOBAL MARKETS (BIO063A) from BCC Research, the global market for DNA diagnostics technology is expected to be worth $10.6 billion in 2008.

read more | digg story

Bookmark and Share


Lab901 raises 3.5m to develop electrophoresis arm

April 29, 2008

Lab901 has raised £3.5m in funding, which will go towards expanding its sales efforts and new products for RNA and Protein Electrophoresis – a market that is currently worth $1.3bn worldwide and expected to increase to over $1.6bn.

The money raised from this latest equity funding round is expected to build on the company’s D800 ScreenTape, a system designed for DNA analysis that is the first product from a pipeline of consumables that will be run on the company’s TapeStation instrument.¹

read more | digg story

¹Lab Technologist, LabTechnologist.com

Bookmark and Share
StumbleUpon